1. Home
  2. CIA vs MDWD Comparison

CIA vs MDWD Comparison

Compare CIA & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Inc. ($1.00 Par)

CIA

Citizens Inc. ($1.00 Par)

HOLD

Current Price

$4.58

Market Cap

251.0M

Sector

Finance

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$15.05

Market Cap

224.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIA
MDWD
Founded
1969
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Life Insurance
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
251.0M
224.6M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
CIA
MDWD
Price
$4.58
$15.05
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
144.5K
65.7K
Earning Date
03-12-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$255,616,000.00
N/A
Revenue This Year
$3.10
$48.88
Revenue Next Year
$4.47
$35.08
P/E Ratio
$28.23
N/A
Revenue Growth
4.33
N/A
52 Week Low
$2.90
$14.14
52 Week High
$6.40
$22.51

Technical Indicators

Market Signals
Indicator
CIA
MDWD
Relative Strength Index (RSI) 36.21 31.36
Support Level $4.53 N/A
Resistance Level $5.44 $18.58
Average True Range (ATR) 0.31 0.59
MACD -0.02 -0.15
Stochastic Oscillator 18.75 10.15

Price Performance

Historical Comparison
CIA
MDWD

About CIA Citizens Inc. ($1.00 Par)

Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: